Akari Therapeutics
AKTX
11 hedge funds and large institutions have $2.16M invested in Akari Therapeutics in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.
9% more capital invested
Capital invested by funds: $1.99M → $2.16M (+$173K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
21% less funds holding
Funds holding: 14 → 11 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OFW
Omnia Family Wealth
Aventura,
Florida
|
+$322K |
| 2 |
BMCM
Bryn Mawr Capital Management
Philadelphia,
Pennsylvania
|
+$161K |
| 3 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$33.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$62K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$33K |
| 3 |
HF
HRT Financial
New York
|
-$31K |
| 4 |
Millennium Management
New York
|
-$25K |
| 5 |
Renaissance Technologies
New York
|
-$9.03K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OFW
1
Omnia Family Wealth
Aventura,
Florida
| $1M | +$322K | +250 | +43% |
|
|
NMC
2
NEA Management Company
Timonium,
Maryland
| $678K | – | – | – |
|
|
BMCM
3
Bryn Mawr Capital Management
Philadelphia,
Pennsylvania
| $150K | +$161K | +125 | New |
|
|
HP
4
Hikari Power
Tokyo,
Japan
| $135K | – | – | – |
|
|
5
Renaissance Technologies
New York
| $90K | -$9.03K | -7 | -9% |
|
6
Geode Capital Management
Boston,
Massachusetts
| $45K | – | – | – |
|
|
CAN
7
Cetera Advisor Networks
El Segundo,
California
| $32K | +$33.5K | +26 | New |
|
8
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $18K | – | – | – |
|
9
Morgan Stanley
New York
| $8K | – | – | – |
|
10
Bank of America
Charlotte,
North Carolina
| $4K | – | – | – |
|
|
TC
11
Truvestments Capital
Sarasota,
Florida
| $2K | – | – | – |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$62K | -47 | Closed |
|
|
13
HighTower Advisors
Chicago,
Illinois
| – | -$33K | -25 | Closed |
|
|
HF
14
HRT Financial
New York
| – | -$31K | -24 | Closed |
|
|
15
Millennium Management
New York
| – | -$25K | -19 | Closed |
|
16
UBS Group
Zurich,
Switzerland
| – | -$2K | -1 | Closed |
|
AKTX Hedge Fund Activity: Q4 2021 in Review
11 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Akari Therapeutics (AKTX) for Q4 2021, worth a combined $2.16M — up 8.7% from $1.99M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of AKTX and 2 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Omnia Family Wealth, adding an estimated $322K. The largest seller was Citadel Advisors, exiting entirely with an estimated $62K sold.
- 11 institutional investors held Akari Therapeutics (AKTX) as of Q4 2021, down from 14 in Q3 2021.
- Funds reported $2.16M of Akari Therapeutics stock for Q4 2021, up 8.7% quarter-over-quarter.
- 2 funds opened new Akari Therapeutics positions in Q4 2021 and 5 closed out, a net change of -3 holders.
- The largest Akari Therapeutics buyer in Q4 2021 was Omnia Family Wealth, an estimated $322K added.
- The largest Akari Therapeutics seller in Q4 2021 was Citadel Advisors, an estimated $62K sold.
Based on aggregated 13F filings for Q4 2021.